iBio, Inc
- Biotech or pharma, therapeutic R&D
ibio is an AI-driven antibody discovery Platform including patented Epitope steering, StableHu™, EngageTx™, and ShieldTx®. ibio’s internal pipeline consists of 5 cardiometabolic/obesity programs (3 of which are partnered), and 6 pre-clinical immuno-oncology programs which are available for partnering.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}